Recombinant Mouse CCL6 Protein, N-His

CCL6, also known as liver-derived chemokine (LDC), is a member of the C-C motif chemokine family and plays a crucial role in the immune response and inflammation. Its primary function involves attracting immune cells to sites of injury or infection, thereby influencing various physiological and pathophysiological processes. In recent years, research has increasingly focused on CCL6 due to its potential implications in various diseases, including autoimmune disorders, cancer, and chronic inflammation. Studies have demonstrated that CCL6 is involved in modulating the migration and activation of T cells and monocytes, highlighting its importance in both innate and adaptive immunity. Recombinant CCL6 protein is utilized in laboratory settings to investigate its signaling pathways and interactions with specific receptors, offering insights into its functions and mechanisms. Furthermore, understanding the role of CCL6 in disease progression may lead to the development of novel therapeutic strategies, such as targeted therapies that aim to modulate its activity. The exploration of CCL6 not only enhances our comprehension of immune regulation but also opens avenues for innovative approaches to treat diseases characterized by dysregulated immune responses. Overall, research on recombinant CCL6 protein holds significant promise for elucidating the complexities of immune system dynamics and the development of potential clinical applications.